Hooper W D, Treston A M, Jacobsen N W, Dickinson R G, Eadie M J
Drug Metab Dispos. 1983 Nov-Dec;11(6):607-10.
Urine specimens from rats and humans who received single doses of primidone (PRM) have been investigated by GC/MS procedures. In addition to the previously documented metabolites of PRM, a small chromatographic peak was encountered which had a mass spectrum suggesting a hydroxy-PRM derivative. Synthesis of p-hydroxy-PRM from PRM was effected; the para isomer was separated from unwanted isomers by preparative HPLC. The PMR spectrum of the synthetic compound proved the position of the hydroxy substituent to be para. This compound had identical GC retention time and an almost identical mass spectrum with that obtained in the urinary extracts. Para-hydroxy-PRM was therefore confirmed as a new, minor metabolite of PRM in rat and man.
已通过气相色谱/质谱法(GC/MS)对接受单剂量扑米酮(PRM)的大鼠和人类的尿液样本进行了研究。除了先前记录的PRM代谢产物外,还遇到了一个小的色谱峰,其质谱表明是一种羟基-PRM衍生物。已由PRM合成了对羟基-PRM;通过制备型高效液相色谱法(HPLC)将对位异构体与不需要的异构体分离。合成化合物的核磁共振氢谱(PMR)证明羟基取代基的位置为对位。该化合物与在尿提取物中获得的化合物具有相同的气相色谱保留时间和几乎相同的质谱。因此,对羟基-PRM被确认为PRM在大鼠和人类中的一种新的次要代谢产物。